GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TARO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Taro Pharmaceutical Industries Ltd stock price after Wednesday trading.
(Updated on Apr 17, 2024)

Hold candidate since Apr 17, 2024 PDF

The Taro Pharmaceutical Industries Ltd stock price gained 0.452% on the last trading day (Wednesday, 17th Apr 2024), rising from $42.05 to $42.24. During the last trading day the stock fluctuated 0.83% from a day low at $42.13 to a day high of $42.48. The price has fallen in 5 of the last 10 days and is down by -0.14% for this period. Volume fell on the last day by -6 thousand shares and in total, 15 thousand shares were bought and sold for approximately $621.60 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the narrow and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. $42.21 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach $43.74 sometime during the next 3 months.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TARO Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -0.236%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The Taro Pharmaceutical Industries Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $42.12 and $42.09. A breakdown below any of these levels will issue sell signals. The stock had a Golden Star Signal on Tuesday, March 26, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Tuesday, March 26, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Taro Pharmaceutical Industries Ltd stock

Taro Pharmaceutical Industries Ltd finds support from accumulated volume at $42.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.350 between high and low, or 0.83%. For the last week the stock has had daily average volatility of 0.492%

Our recommended stop-loss: $39.62 (-6.21%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (TARO) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Taro Pharmaceutical Industries Ltd to open at $42.28, and during the day (based on 14 day Average True Range), to move between $41.95 and $42.53, which gives a possible trading interval of +/-$0.291 (+/-0.69%) up or down from last closing price. If Taro Pharmaceutical Industries Ltd takes out the full calculated possible swing range there will be an estimated 1.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $42.23 (0.02%) than the resistance at $42.34 (0.24%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Taro Pharmaceutical Industries Ltd stock A Buy?

Taro Pharmaceutical Industries Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.708 Hold/Accumulate Upgraded

Predicted Opening Price for Taro Pharmaceutical Industries Ltd of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$42.28 ( 0.103%) $42.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TARO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 42.63 0.93 %
R2 42.50 0.615 %
R1 42.42 0.419 %
Current price: 42.24
Support S1 42.15 -0.214 %
S2 42.07 -0.409 %
S3 41.93 -0.726 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 43.33 2.58 %
R2 43.28 2.46 %
R1 42.34 0.237 %
Current price 42.24
Support S1 42.23 -0.0237%
S2 42.13 -0.260%
S3 40.97 -3.01%

TARO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Nov 05, 2018 Dec 10, 2018 Dec 28, 2018 $12.81 15.12%

FAQ

What is the symbol for Taro Pharmaceutical Industries Ltd Stock and on which exchange is it traded?
The symbol for Taro Pharmaceutical Industries Ltd is TARO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Taro Pharmaceutical Industries Ltd Stock?
Taro Pharmaceutical Industries Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Taro Pharmaceutical Industries Ltd Stock?
Taro Pharmaceutical Industries Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Taro Pharmaceutical Industries Ltd Stock.

What's the current price of Taro Pharmaceutical Industries Ltd Stock?
As of the end of day on the 2024-04-17, the price of an Taro Pharmaceutical Industries Ltd (TARO) share was $42.24.

What is the 52-week high and low for Taro Pharmaceutical Industries Ltd Stock?
The 52-week high for Taro Pharmaceutical Industries Ltd Stock is $45.76 and the 52-week low is $24.22.

What is the market capitalization of Taro Pharmaceutical Industries Ltd Stock?
As of the 2024-04-17, the market capitalization of Taro Pharmaceutical Industries Ltd is 1.588B.

When is the next earnings date for Taro Pharmaceutical Industries Ltd?
The upcoming earnings date for Taro Pharmaceutical Industries Ltd is May 28, 2024.
Click to get the best stock tips daily for free!

About Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic,... TARO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT